Hodgkin's Lymphoma

TL;DR

Hodgkin's Lymphoma causes uncontrolled lymphocyte growth and swollen lymph nodes.

Transcript

foreign what's up Ninja nerds in this video today we're going to be talking about Hodgkin's lymphoma before we get started if you guys like this video it makes sense for you please support us one of the best ways that you guys truly can do that is by hitting that like button commenting down the comment section and please sub... Read More

Key Insights

• Hodgkin's Lymphoma involves an alteration in the lymphocyte pathway, particularly affecting B cells rather than T cells.
• The disease is marked by the presence of Reed-Sternberg cells, which are abnormal B cells that do not undergo apoptosis.
• The accumulation of Reed-Sternberg cells in lymph nodes leads to lymphadenopathy, often presenting as painless, rubbery, and contiguous swelling.
• B symptoms, such as fever, night sweats, and weight loss, are common due to cytokine release by Reed-Sternberg cells.
• Diagnosis involves lymph node biopsy to identify Reed-Sternberg cells, with further classification using flow cytometry.
• Staging of the disease is done using the Ann Arbor system, considering lymph node involvement and extra-nodal spread.
• Treatment for classical Hodgkin's Lymphoma includes ABVD therapy, while non-classical types may benefit from rituximab.
• Refractory cases may require targeted therapies like Brentuximab Vedotin, especially if CD30 positive.

Questions & Answers

Q: What is the primary cell type affected in Hodgkin's Lymphoma?

Hodgkin's Lymphoma primarily affects B cells in the lymphocyte pathway. These B cells, upon failing to undergo apoptosis, transform into Reed-Sternberg cells, which accumulate in the lymph nodes, causing the characteristic symptoms of the disease.

Q: How are Reed-Sternberg cells identified in Hodgkin's Lymphoma?

Reed-Sternberg cells are identified through a lymph node biopsy, where their presence is confirmed by their distinct appearance under the microscope. Flow cytometry can further classify these cells based on surface proteins, such as CD15 and CD30, which are typical of classical Hodgkin's Lymphoma.

Q: What are the common symptoms associated with Hodgkin's Lymphoma?

Common symptoms of Hodgkin's Lymphoma include lymphadenopathy, which presents as painless, rubbery swelling of lymph nodes, and B symptoms like fever, night sweats, and weight loss. These symptoms are often due to cytokine release by Reed-Sternberg cells, affecting various tissues and organs.

Q: What is the significance of B symptoms in Hodgkin's Lymphoma?

B symptoms, which include fever, night sweats, and weight loss, are significant as they indicate systemic involvement and are often associated with a more aggressive disease course. These symptoms result from cytokine release by Reed-Sternberg cells and can affect the staging and prognosis of Hodgkin's Lymphoma.

Q: How is Hodgkin's Lymphoma staged?

Hodgkin's Lymphoma is staged using the Ann Arbor system, which considers the number and location of affected lymph nodes and the presence of extra-nodal involvement. Stages range from I to IV, with additional subclassifications for B symptoms and bulky disease, which help guide treatment decisions.

Q: What are the main treatment options for classical Hodgkin's Lymphoma?

Classical Hodgkin's Lymphoma is commonly treated with the ABVD chemotherapy regimen, which includes Adriamycin, Bleomycin, Vinblastine, and Dacarbazine. In advanced stages, more intensive regimens like BEACOPP may be used, depending on the extent of the disease and the presence of extra-nodal involvement.

Q: What role does rituximab play in treating Hodgkin's Lymphoma?

Rituximab is used primarily in the treatment of non-classical Hodgkin's Lymphoma, particularly in cases with nodular lymphocyte predominant Hodgkin's Lymphoma. This monoclonal antibody targets CD20 on B cells, helping to reduce the proliferation of cancerous cells in this subtype of the disease.

Q: What are the potential side effects of Hodgkin's Lymphoma treatments?

Treatments for Hodgkin's Lymphoma, such as ABVD chemotherapy, can have side effects including pulmonary fibrosis from Bleomycin and cardiomyopathy from Doxorubicin. Monitoring lung and heart function through pulmonary function tests and echocardiograms is essential to manage these potential toxicities during treatment.

Summary & Key Takeaways

• Hodgkin's Lymphoma is a cancer affecting the lymphatic system, characterized by uncontrolled growth of lymphocytes, particularly B cells. It results in swollen lymph nodes and systemic symptoms due to cytokine release.

• Reed-Sternberg cells, a hallmark of Hodgkin's Lymphoma, fail to undergo apoptosis, leading to their accumulation in lymph nodes. Diagnosis is confirmed via biopsy, identifying these cells.

• Treatment varies by stage and subtype, with classical Hodgkin's Lymphoma treated using ABVD chemotherapy, while non-classical types may require rituximab. Advanced cases may need targeted therapy.